Literature DB >> 33096187

Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis.

Hassan Alwafi1, Alaa A Alsharif2, Li Wei3, Dean Langan4, Abdallah Y Naser5, Pajaree Mongkhon6, J Simon Bell7, Jenni Ilomaki7, Mansour S Al Metwazi8, Kenneth K C Man9, Gang Fang10, Ian C K Wong11.   

Abstract

BACKGROUND: Previous meta-analysis investigating the incidence and prevalence of hypoglycaemia in both types of diabetes is limited. The purpose of this review is to conduct a systematic review and meta-analysis of the existing literature which investigates the incidence and prevalence of hypoglycaemia in individuals with diabetes.
METHODS: PubMed, Embase and Cochrane library databases were searched up to October 2018. Observational studies including individuals with diabetes of all ages and reporting incidence and/or prevalence of hypoglycaemia were included. Two reviewers independently screened articles, extracted data and assessed the quality of included studies. Meta-analysis was performed using a random effects model with 95% confidence interval (CI) to estimate the pooled incidence and prevalence of hypoglycaemia in individuals with diabetes.
RESULTS: Our search strategy generated 35,007 articles, of which 72 studies matched the inclusion criteria and were included in the meta-analysis. The prevalence of hypoglycaemia ranged from 0.074% to 73.0%, comprising a total of 2,462,810 individuals with diabetes. The incidence rate of hypoglycaemia ranged from 0.072 to 42,890 episodes per 1,000 person-years: stratified by type of diabetes, it ranged from 14.5 to 42,890 episodes per 1,000 person-years and from 0.072 to 16,360 episodes per 1,000-person years in type 1 and type 2 diabetes, respectively.
CONCLUSION: Hypoglycaemia is very common among individuals with diabetes. Further studies are needed to investigate hypoglycaemia-associated risk factors.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Incidence; Meta-analysis; Prevalence; Type 1 diabetes; Type 2 Diabetes

Mesh:

Year:  2020        PMID: 33096187     DOI: 10.1016/j.diabres.2020.108522

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study.

Authors:  Anxious J Niwaha; Lauren R Rodgers; Alice L J Carr; Priscilla A Balungi; Raymond Mwebaze; Andrew T Hattersley; Beverley M Shields; Moffat J Nyirenda; Angus G Jones
Journal:  BMJ Open Diabetes Res Care       Date:  2022-04

Review 2.  Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review.

Authors:  Yaguang Zheng; Victoria Vaughan Dickson; Saul Blecker; Jason M Ng; Brynne Campbell Rice; Gail D'Eramo Melkus; Liat Shenkar; Marie Claire R Mortejo; Stephen B Johnson
Journal:  JMIR Diabetes       Date:  2022-05-16

Review 3.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

4.  The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: "What am I going to do?"

Authors:  Heather L Stuckey; Urvi Desai; Sarah B King; Lyuba Popadic; William Levinson; Noam Y Kirson; Emily R Hankosky; Beth Mitchell
Journal:  Diabet Med       Date:  2021-12-15       Impact factor: 4.213

Review 5.  The safety and efficacy of the use of oral anticoagulant medications in patients with diabetes mellitus: A systematic review.

Authors:  Hassan Alwafi; Basil Alotaibi; Abdallah Y Naser; Emad Salawati; Sami Qadus; Kanar Sweiss; Mohammad S Dairi; Loay Hassouneh; Yousef Aldalameh; Mohammed Samannodi
Journal:  Saudi Pharm J       Date:  2021-11-12       Impact factor: 4.330

6.  Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia.

Authors:  Antonio J Martínez-Ortega; Cristina Muñoz-Gómez; Noelia Gros-Herguido; Pablo Jesús Remón-Ruiz; Domingo Acosta-Delgado; Fernando Losada-Viñau; Alfonso Pumar-López; Miguel Ángel Mangas-Cruz; Irene González-Navarro; Gema López-Gallardo; Virginia Bellido; Alfonso Manuel Soto-Moreno
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.